Cargando…

In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications

The human adenovirus phylogenetic tree is split across seven species (A–G). Species D adenoviruses offer potential advantages for gene therapy applications, with low rates of pre-existing immunity detected across screened populations. However, many aspects of the basic virology of species D—such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bates, Emily A., Counsell, John R., Alizert, Sophie, Baker, Alexander T., Suff, Natalie, Boyle, Ashley, Bradshaw, Angela C., Waddington, Simon N., Nicklin, Stuart A., Baker, Andrew H., Parker, Alan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402785/ https://www.ncbi.nlm.nih.gov/pubmed/34452348 http://dx.doi.org/10.3390/v13081483

Ejemplares similares

Efficient Transduction of Primary Vascular Cells by the Rare Adenovirus Serotype 49 Vector
por: Dakin, Rachel S., et al.
Publicado: (2015)

Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenoviruses
por: Bradshaw, Angela C., et al.
Publicado: (2012)

Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X
por: Bradshaw, Angela C., et al.
Publicado: (2010)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010)

Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum
por: Lopez-Gordo, Estrella, et al.
Publicado: (2017)

Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo
por: Doszpoly, Andor, et al.
Publicado: (2019)

The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry Mechanism
por: Baker, Alexander T., et al.
Publicado: (2021)

The relevance of coagulation factor X protection of adenoviruses in human sera
por: Duffy, M R, et al.
Publicado: (2016)

Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo
por: Ma, Jiangtao, et al.
Publicado: (2015)

Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profile
por: White, Katie M, et al.
Publicado: (2013)

Designer Oncolytic Adenovirus: Coming of Age
por: Baker, Alexander T., et al.
Publicado: (2018)

Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022)

A trial of somatic gene targeting in vivo with an adenovirus vector
por: Ino, Asami, et al.
Publicado: (2005)

Pseudotyping the adenovirus serotype 5 capsid with both the fibre and penton of serotype 35 enhances vascular smooth muscle cell transduction
por: Parker, A L, et al.
Publicado: (2013)

Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2015)

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies
por: Cunliffe, Tabitha G., et al.
Publicado: (2020)

Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004)

Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective
por: JT, Schwartze, et al.
Publicado: (2022)

Rapid and inexpensive purification of adenovirus vectors using an optimised aqueous two-phase technology
por: Suleman, Saqlain, et al.
Publicado: (2022)

Evidence for Contribution of CD4+CD25+ Regulatory T Cells in Maintaining Immune Tolerance to Human Factor IX following Perinatal Adenovirus Vector Delivery
por: Nivsarkar, Megha S., et al.
Publicado: (2015)

Covalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexes
por: Kratzer, Ramona F., et al.
Publicado: (2017)

Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors
por: Karda, Rajvinder, et al.
Publicado: (2020)

Simian adenoviruses as vaccine vectors
por: Morris, Susan J, et al.
Publicado: (2016)

Adenovirus Vectors Target Several Cell Subtypes of Mammalian Inner Ear In Vivo
por: Shu, Yilai, et al.
Publicado: (2016)

Production of lentiviral vectors using novel, enzymatically produced, linear DNA
por: Karda, Rajvinder, et al.
Publicado: (2019)

Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop
por: Robertson, Stacy, et al.
Publicado: (2016)

Development of nonhuman adenoviruses as vaccine vectors
por: Bangari, Dinesh S., et al.
Publicado: (2006)

Increasing the Efficacy of Oncolytic Adenovirus Vectors
por: Toth, Karoly, et al.
Publicado: (2010)

Measurement of Adenovirus-Based Vector Heterogeneity
por: Hickey, John M., et al.
Publicado: (2023)

Adenovirus as a Vector and Oncolytic Virus
por: Matsunaga, Wataru, et al.
Publicado: (2023)

High-level production of replication-defective human immunodeficiency type 1 virus vector particles using helper-dependent adenovirus vectors
por: Hu, Yani, et al.
Publicado: (2015)

Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2016)

Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo
por: Tartaglia, Lawrence J., et al.
Publicado: (2019)

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo
por: Tian, Jie, et al.
Publicado: (2022)

Human adenovirus type 26 uses sialic acid–bearing glycans as a primary cell entry receptor
por: Baker, Alexander T., et al.
Publicado: (2019)

Adenovirus Dodecahedron, as a Drug Delivery Vector
por: Zochowska, Monika, et al.
Publicado: (2009)

Adenoviruses as vectors for delivering vaccines to mucosal surfaces
por: Babiuk, L.A, et al.
Publicado: (2000)

Species D Adenoviruses as Oncolytic Viral Vectors
por: Bullard, Brianna L., et al.
Publicado: (2020)

Adenovirus Vectors: Excellent Tools for Vaccine Development
por: Chang, Jun
Publicado: (2021)

COVID-19 Vaccines Based on Adenovirus Vectors
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o7i02kd6dp8du5pul9e8vm0kfd